138 related articles for article (PubMed ID: 20739362)
21. Protein phosphorylation and kinome profiling reveal altered regulation of multiple signaling pathways in B lymphocytes from patients with systemic lupus erythematosus.
Taher TE; Parikh K; Flores-Borja F; Mletzko S; Isenberg DA; Peppelenbosch MP; Mageed RA
Arthritis Rheum; 2010 Aug; 62(8):2412-23. PubMed ID: 20506108
[TBL] [Abstract][Full Text] [Related]
22. TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients.
Wu P; Wu J; Liu S; Han X; Lu J; Shi Y; Wang J; Lu L; Cao X
Clin Immunol; 2008 Oct; 129(1):40-8. PubMed ID: 18684674
[TBL] [Abstract][Full Text] [Related]
23. Blockade of TLR9 agonist-induced type I interferons promotes inflammatory cytokine IFN-gamma and IL-17 secretion by activated human PBMC.
Meyers JA; Mangini AJ; Nagai T; Roff CF; Sehy D; van Seventer GA; van Seventer JM
Cytokine; 2006 Sep; 35(5-6):235-46. PubMed ID: 17052915
[TBL] [Abstract][Full Text] [Related]
24. Toll-like receptor activation in the pathogenesis of systemic lupus erythematosus.
Means TK; Luster AD
Ann N Y Acad Sci; 2005 Dec; 1062():242-51. PubMed ID: 16461805
[TBL] [Abstract][Full Text] [Related]
25. Potentiation of TLR9 responses for human naïve B-cell growth through RP105 signaling.
Yamazaki K; Yamazaki T; Taki S; Miyake K; Hayashi T; Ochs HD; Agematsu K
Clin Immunol; 2010 Apr; 135(1):125-36. PubMed ID: 20133206
[TBL] [Abstract][Full Text] [Related]
26. IFN-alpha amplifies human naive B cell TLR-9-mediated activation and Ig production.
Giordani L; Sanchez M; Libri I; Quaranta MG; Mattioli B; Viora M
J Leukoc Biol; 2009 Aug; 86(2):261-71. PubMed ID: 19401392
[TBL] [Abstract][Full Text] [Related]
27. Toll-like receptor engagement stimulates anti-snRNP autoreactive B cells for activation.
Ding C; Wang L; Al-Ghawi H; Marroquin J; Mamula M; Yan J
Eur J Immunol; 2006 Aug; 36(8):2013-24. PubMed ID: 16810634
[TBL] [Abstract][Full Text] [Related]
28. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus.
Christensen SR; Shupe J; Nickerson K; Kashgarian M; Flavell RA; Shlomchik MJ
Immunity; 2006 Sep; 25(3):417-28. PubMed ID: 16973389
[TBL] [Abstract][Full Text] [Related]
29. Expression of Toll-like receptor 9 in renal podocytes in childhood-onset active and inactive lupus nephritis.
Machida H; Ito S; Hirose T; Takeshita F; Oshiro H; Nakamura T; Mori M; Inayama Y; Yan K; Kobayashi N; Yokota S
Nephrol Dial Transplant; 2010 Aug; 25(8):2530-537. PubMed ID: 20181802
[TBL] [Abstract][Full Text] [Related]
30. Autoantibody-producing RP105(-) B cells, from patients with systemic lupus erythematosus, showed more preferential expression of BCMA compared with BAFF-R than normal subjects.
Koarada S; Tada Y; Sohma Y; Haruta Y; Suematsu R; Mitamura M; Inoue H; Ehara H; Tokoro Y; Ohta A; Nagasawa K
Rheumatology (Oxford); 2010 Apr; 49(4):662-70. PubMed ID: 20097906
[TBL] [Abstract][Full Text] [Related]
31. Impaired TLR9 responses in B cells from patients with systemic lupus erythematosus.
Gies V; Schickel JN; Jung S; Joublin A; Glauzy S; Knapp AM; Soley A; Poindron V; Guffroy A; Choi JY; Gottenberg JE; Anolik JH; Martin T; Soulas-Sprauel P; Meffre E; Korganow AS
JCI Insight; 2018 Mar; 3(5):. PubMed ID: 29515028
[TBL] [Abstract][Full Text] [Related]
32. IVIg attenuates TLR-9 activation in B cells from SLE patients.
Kessel A; Peri R; Haj T; Snir A; Slobodin G; Sabo E; Rosner I; Shoenfeld Y; Toubi E
J Clin Immunol; 2011 Feb; 31(1):30-8. PubMed ID: 20922561
[TBL] [Abstract][Full Text] [Related]
33. B cell-intrinsic TLR9 expression is protective in murine lupus.
Tilstra JS; John S; Gordon RA; Leibler C; Kashgarian M; Bastacky S; Nickerson KM; Shlomchik MJ
J Clin Invest; 2020 Jun; 130(6):3172-3187. PubMed ID: 32191633
[TBL] [Abstract][Full Text] [Related]
34. CpG oligonucleotides induce an immune response of odontoblasts through the TLR9, MyD88 and NF-kappaB pathways.
He W; Yu Q; Zhou Z; Wang P
Biochem Biophys Res Commun; 2010 Aug; 399(2):274-8. PubMed ID: 20655295
[TBL] [Abstract][Full Text] [Related]
35. Constitutive expression of IL-6 receptors and their role in the excessive B cell function in patients with systemic lupus erythematosus.
Nagafuchi H; Suzuki N; Mizushima Y; Sakane T
J Immunol; 1993 Dec; 151(11):6525-34. PubMed ID: 8245483
[TBL] [Abstract][Full Text] [Related]
36. Decreased IL-10 production mediated by Toll-like receptor 9 in B cells in multiple sclerosis.
Hirotani M; Niino M; Fukazawa T; Kikuchi S; Yabe I; Hamada S; Tajima Y; Sasaki H
J Neuroimmunol; 2010 Apr; 221(1-2):95-100. PubMed ID: 20227772
[TBL] [Abstract][Full Text] [Related]
37. Persistent expression of autoantibodies in SLE patients in remission.
Yurasov S; Tiller T; Tsuiji M; Velinzon K; Pascual V; Wardemann H; Nussenzweig MC
J Exp Med; 2006 Oct; 203(10):2255-61. PubMed ID: 16966430
[TBL] [Abstract][Full Text] [Related]
38. Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice.
Santiago-Raber ML; Dunand-Sauthier I; Wu T; Li QZ; Uematsu S; Akira S; Reith W; Mohan C; Kotzin BL; Izui S
J Autoimmun; 2010 Jun; 34(4):339-48. PubMed ID: 19944565
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of spontaneous activation of B cells in patients with systemic lupus erythematosus. Analysis with anti-class II antibody.
Tanaka Y; Shirakawa F; Ota T; Suzuki H; Eto S; Yamashita U
J Immunol; 1988 Feb; 140(3):761-7. PubMed ID: 3276779
[TBL] [Abstract][Full Text] [Related]
40. The largely normal response to Toll-like receptor 7 and 9 stimulation and the enhanced expression of SIGIRR by B cells in systemic lupus erythematosus.
Zhu YY; Su Y; Li ZG; Zhang Y
PLoS One; 2012; 7(8):e44131. PubMed ID: 22952899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
